Nano TransMed最新文献

筛选
英文 中文
Recent advances in electrochemical biosensors for bacterial detection 用于细菌检测的电化学生物传感器研究进展
Nano TransMed Pub Date : 2025-03-11 DOI: 10.1016/j.ntm.2025.100078
Yunyang Zhou , Qingcui Wang , Ting Xiang , Xiaohua Chen
{"title":"Recent advances in electrochemical biosensors for bacterial detection","authors":"Yunyang Zhou ,&nbsp;Qingcui Wang ,&nbsp;Ting Xiang ,&nbsp;Xiaohua Chen","doi":"10.1016/j.ntm.2025.100078","DOIUrl":"10.1016/j.ntm.2025.100078","url":null,"abstract":"<div><div>Accurate and efficient bacterial detection remains a critical challenge in clinical diagnostics and public health. Conventional methods are often constrained by low sensitivity and labor-intensive workflows. In contrast, electrochemical sensors offer distinct advantages: high sensitivity, rapid response, cost-effectiveness, and ease of use. The advancement of electrochemical sensors for bacterial detection relies on the continuous optimization of fundamental sensing architectures and the integration of advanced technologies. This review adopts a dual foundation-to-frontier framework. Analyzing essential sensor components such as functional nanomaterials for interface engineering, precisely engineered biorecognition elements, and established electrochemical detection methodologies. Simultaneously, through an advanced technological lens, we explore cutting-edge interdisciplinary innovations such as dual-modal sensing systems, flexible sensor architectures, and artificial intelligence-driven analytical systems. By synthesizing foundational principles and technological innovations, this review not only informs rational sensor design but also delineates the transition toward miniaturized, intelligent, and high-throughput systems for precision medicine and environmental monitoring. This work aims to offer forward-looking guidance for the future development of bacterial detection technologies.</div></div>","PeriodicalId":100941,"journal":{"name":"Nano TransMed","volume":"4 ","pages":"Article 100078"},"PeriodicalIF":0.0,"publicationDate":"2025-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143619112","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The delivery and transmembrane transport mechanism of SVCV nanovaccine SVCV纳米疫苗的传递和跨膜转运机制
Nano TransMed Pub Date : 2025-03-03 DOI: 10.1016/j.ntm.2025.100077
Han Zhang , Pan-pan Zhang , Xin-Xin Liu , Hai-hua Peng , Qun Liu , Jun Wang , Bin Zhu , Yong-Can Zhou , Yun Sun , Chen Zhang
{"title":"The delivery and transmembrane transport mechanism of SVCV nanovaccine","authors":"Han Zhang ,&nbsp;Pan-pan Zhang ,&nbsp;Xin-Xin Liu ,&nbsp;Hai-hua Peng ,&nbsp;Qun Liu ,&nbsp;Jun Wang ,&nbsp;Bin Zhu ,&nbsp;Yong-Can Zhou ,&nbsp;Yun Sun ,&nbsp;Chen Zhang","doi":"10.1016/j.ntm.2025.100077","DOIUrl":"10.1016/j.ntm.2025.100077","url":null,"abstract":"<div><div>Spring viremia of carp virus (SVCV) is a fatal microorganism for a variety of cyprinid fish species, sparking off enormous economic losses in freshwater fish aquaculture. For alleviating losses, immersion vaccination is an extremely promising maneuver to prevent and curb on SVCV infection. In our previous research, we designed a modular immersion nanovaccine (LSG-TDH) targeting SVCV, and found that it could induce not merely mucosal immunity but systemic immune responses in zebrafish. Nevertheless, our previous research was unable to elaborate on how LSG-TDH were taken up by the cells. Thereby, this study aimed to investigate its transmembrane transport mechanism <em>in vitro</em> using epithelioma papulosum cyprini (EPC) cells and macrophages as models. The transmembrane transport mechanism of LSG-TDH on EPC cells and macrophages was analyzed by cell fluorescence, flow cytometry and chemical inhibitor experiments. The results showed that the entry of LSG-TDH into cells was time-dependent and energy-dependent. Chlorpromazine significantly inhibited the transmembrane transport of LSG-TDH. The contents of LSG-TDH into EPC cells and macrophages after treated with chlorpromazine decreased by 80 % and 71 %, respectively. It is indicated that the transmembrane transport of LSG-TDH was mainly achieved through clathrin-mediated endocytosis pathway. This study provides a reference for the delivery mechanism of aquatic nanovaccine, which has important scientific significance and application prospect.</div></div>","PeriodicalId":100941,"journal":{"name":"Nano TransMed","volume":"4 ","pages":"Article 100077"},"PeriodicalIF":0.0,"publicationDate":"2025-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143577942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Harnessing nanoparticle technology for precision medicine in head and neck cancer: Targeted delivery, immunomodulation, and clinical translation 利用纳米颗粒技术进行头颈癌的精准医疗:靶向递送、免疫调节和临床转化
Nano TransMed Pub Date : 2025-02-21 DOI: 10.1016/j.ntm.2025.100075
Karthikeyan Elumalai , Sivaneswari Srinivasan
{"title":"Harnessing nanoparticle technology for precision medicine in head and neck cancer: Targeted delivery, immunomodulation, and clinical translation","authors":"Karthikeyan Elumalai ,&nbsp;Sivaneswari Srinivasan","doi":"10.1016/j.ntm.2025.100075","DOIUrl":"10.1016/j.ntm.2025.100075","url":null,"abstract":"<div><div>Head and neck cancer (HNC) remains a significant challenge in oncology due to poor drug delivery and an immunosuppressive tumour microenvironment (TME). This review focuses on the role of nanoparticles (NPs) in addressing challenges in HNC treatment, highlighting their potential to enhance efficiency and targeting. Researchers are studying different kinds of NPs, like liposomal, polymeric, dendritic, and gold nanoparticles (AuNPs), to see how they can improve drug delivery and change the tumour environment. To improve treatment results, we use specific strategies like targeting receptors, releasing substances inside cells in a controlled way, and adjusting the immune response. The review talks about how NPs focus on cancer-related fibroblasts, stop new blood vessel growth, and tackle problems in moving these treatments into real-world use. These issues include safety, toxicity, being able to produce them on a large scale, and following regulations. Finally, emerging trends, such as hybrid NPs and personalized nanomedicine, are proposed. Nanoparticle technology can greatly change how we treat head and neck cancer. It can improve how drugs are delivered, alter the environment around tumours, and tailor treatments to individual patients, which can make life better for them. This could lead to a new approach in cancer care.in cancer treatment.</div></div>","PeriodicalId":100941,"journal":{"name":"Nano TransMed","volume":"4 ","pages":"Article 100075"},"PeriodicalIF":0.0,"publicationDate":"2025-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143488280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bio-nanomaterials: Promising anticancer properties and treatment strategies 生物纳米材料:抗癌特性和治疗策略
Nano TransMed Pub Date : 2025-02-21 DOI: 10.1016/j.ntm.2025.100076
Elias Emeka Elemike , Innocent Chukwujekwu Onunkwo , Odiri Ughumiakpor , Faith Alawuru , Anthony Mukoro , Peter Ishom , Faith Obarakpor , Ismail Hossain , Andrew E. Aziza
{"title":"Bio-nanomaterials: Promising anticancer properties and treatment strategies","authors":"Elias Emeka Elemike ,&nbsp;Innocent Chukwujekwu Onunkwo ,&nbsp;Odiri Ughumiakpor ,&nbsp;Faith Alawuru ,&nbsp;Anthony Mukoro ,&nbsp;Peter Ishom ,&nbsp;Faith Obarakpor ,&nbsp;Ismail Hossain ,&nbsp;Andrew E. Aziza","doi":"10.1016/j.ntm.2025.100076","DOIUrl":"10.1016/j.ntm.2025.100076","url":null,"abstract":"<div><div>One of the most difficult diseases to treat in people is cancer, and its mortality rate has recently increased significantly. Nanoparticles are used in the rapidly developing field of cancer nanomedicine to diagnose and as well treat cancer. The often-systemic effects with conventional therapy have now been minimized by the ability of nanoparticles to release normally considered insoluble medicines to tumor locations both far and near. Due to their strong qualities and effects, which include biocompatibility, biosafety, biodegradability, synergistic and autologous therapeutic effects, biologically-based nanomaterials have drawn great interests with regards to cancer therapy. It has been extensively discussed and discovered that nucleic acid, polysaccharides, polyphenol or phenolics, proteins (also peptide), cell and subcellular fractions, as well as lipid are bioactive substances. The utilization of these biologically-active materials in nano-formulation is promising toward efficient treatment of cancer through by different oncological therapeutic strategies. As a result of their structural characterizations, adaptable characteristics, anti-tumor processes, and biological performances, these bioactive compounds have been specifically used as examples of the functions of composite nanosystems.</div></div>","PeriodicalId":100941,"journal":{"name":"Nano TransMed","volume":"4 ","pages":"Article 100076"},"PeriodicalIF":0.0,"publicationDate":"2025-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143488281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Harnessing silica nanoparticles grafted with ascorbic acid to alleviate oxidative stress and impaired brain activity in rats 利用二氧化硅纳米颗粒嫁接抗坏血酸缓解大鼠氧化应激和脑活动受损
Nano TransMed Pub Date : 2025-01-28 DOI: 10.1016/j.ntm.2025.100074
Essia Hamdi , Slah Hidouri , Ana-Belén Muniz-Gonzalez , Marwa Kechnebbou , Salem Amara
{"title":"Harnessing silica nanoparticles grafted with ascorbic acid to alleviate oxidative stress and impaired brain activity in rats","authors":"Essia Hamdi ,&nbsp;Slah Hidouri ,&nbsp;Ana-Belén Muniz-Gonzalez ,&nbsp;Marwa Kechnebbou ,&nbsp;Salem Amara","doi":"10.1016/j.ntm.2025.100074","DOIUrl":"10.1016/j.ntm.2025.100074","url":null,"abstract":"<div><div>The brain has natural antioxidant defense systems, functioning through enzymes such as superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase, which neutralize reactive oxygen species (ROS). Once these defense systems are overwhelmed by poisoning, oxidative damage can occur in the brain. In this study, hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) was used to induce oxidative stress. Ascorbic acid grafted to silica nanoparticles (SiO<sub>2</sub>-NPs@AA) was used as a therapeutic strategy aimed to reduce ROS levels and enhancing antioxidant defenses. The SiO<sub>2</sub>-NPs@AA were synthesized and characterized, showing efficient functionalization with ascorbic acid. The in-vitro, antioxidant assays revealed that SiO<sub>2</sub>-NPs@AA exhibited significant radical scavenging activity (DPPH and hydroxyl radicals) and high iron-chelating ability with enhanced stability compared to free ascorbic acid. Moreover, the in-vivo study demonstrated that SiO<sub>2</sub>-NPs@AA mitigated H<sub>2</sub>O<sub>2</sub>-induced effects in key enzymes, including superoxide dismutase, catalase, glutathione (GSH), and restore acetylcholinesterase (AChE) levels. Notably, malondialdehyde (MDA) levels, a marker of lipid peroxidation, were significantly reestablished in the frontal cortex and hippocampus following SiO<sub>2</sub>-NPs@AA. Overall, the study revealed that SiO<sub>2</sub>-NPs@AA corrected effectively nitric oxide (NO) and monoamine oxidase activities, which confirm their role to preserve neuronal function and mitigate neurotoxicity.</div></div>","PeriodicalId":100941,"journal":{"name":"Nano TransMed","volume":"4 ","pages":"Article 100074"},"PeriodicalIF":0.0,"publicationDate":"2025-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143154059","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erratum regarding previously published articles 关于以前发表的文章的勘误
Nano TransMed Pub Date : 2025-01-22 DOI: 10.1016/j.ntm.2025.100072
{"title":"Erratum regarding previously published articles","authors":"","doi":"10.1016/j.ntm.2025.100072","DOIUrl":"10.1016/j.ntm.2025.100072","url":null,"abstract":"","PeriodicalId":100941,"journal":{"name":"Nano TransMed","volume":"4 ","pages":"Article 100072"},"PeriodicalIF":0.0,"publicationDate":"2025-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143154057","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Graphene nanomaterial-based electrochemical biosensors for salivary biomarker detection: A translational approach to oral cancer diagnostics 基于石墨烯纳米材料的唾液生物标志物检测电化学生物传感器:口腔癌诊断的转化方法
Nano TransMed Pub Date : 2025-01-22 DOI: 10.1016/j.ntm.2025.100073
D. Mahalakshmi , J. Nandhini , G. Meenaloshini , E. Karthikeyan , KK Karthik , J. Sujaritha , Vandhana V , C. Ragavendran
{"title":"Graphene nanomaterial-based electrochemical biosensors for salivary biomarker detection: A translational approach to oral cancer diagnostics","authors":"D. Mahalakshmi ,&nbsp;J. Nandhini ,&nbsp;G. Meenaloshini ,&nbsp;E. Karthikeyan ,&nbsp;KK Karthik ,&nbsp;J. Sujaritha ,&nbsp;Vandhana V ,&nbsp;C. Ragavendran","doi":"10.1016/j.ntm.2025.100073","DOIUrl":"10.1016/j.ntm.2025.100073","url":null,"abstract":"<div><div>Graphene-based electrochemical biosensors have emerged as promising tools for the early detection and monitoring of oral cancer through salivary biomarker analysis. Graphene's exceptional properties, including high surface area, superior electrical conductivity, and excellent mechanical strength, enable the development of highly sensitive and specific biosensors. This review provides a comprehensive overview of the current state-of-the-art in graphene-based electrochemical biosensors for salivary biomarker detection in oral cancer. We discuss the unique advantages of saliva as a diagnostic medium and highlight the key salivary biomarkers associated with oral cancer, including proteins, DNA, and RNA. Various electrochemical detection techniques, such as cyclic voltammetry, differential pulse voltammetry, electrochemical impedance spectroscopy, field-effect transistors, amperometry, chronoamperometry, and photoelectrochemical methods, are explored in the context of graphene-based biosensors. The challenges associated with the development and clinical translation of these biosensors are also addressed, emphasizing the need for improved functionalization strategies, enhanced stability, and standardized validation protocols. Finally, we present a futuristic outlook on the integration of graphene-based biosensors with artificial intelligence, microfluidics, and telemedicine platforms to enable personalized diagnostics and treatment monitoring. With continued advancements in sensor technology and computational tools, graphene-based electrochemical biosensors have the potential to revolutionize oral cancer management, improving patient outcomes and quality of life.</div></div>","PeriodicalId":100941,"journal":{"name":"Nano TransMed","volume":"4 ","pages":"Article 100073"},"PeriodicalIF":0.0,"publicationDate":"2025-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143154061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PROTAC-based therapeutics for targeting HPV oncoproteins in head and neck cancers 靶向头颈癌HPV癌蛋白的基于protac的治疗方法
Nano TransMed Pub Date : 2025-01-16 DOI: 10.1016/j.ntm.2025.100071
Nobendu Mukerjee , Dattatreya Mukherjee
{"title":"PROTAC-based therapeutics for targeting HPV oncoproteins in head and neck cancers","authors":"Nobendu Mukerjee ,&nbsp;Dattatreya Mukherjee","doi":"10.1016/j.ntm.2025.100071","DOIUrl":"10.1016/j.ntm.2025.100071","url":null,"abstract":"<div><div>The increasing incidence of Human Papillomavirus (HPV)-related head and neck cancers, particularly oropharyngeal squamous cell carcinomas, highlights the need for advanced therapeutic options beyond the traditional modalities of surgery, radiation, and chemotherapy, which often lead to significant morbidity and lack specificity in targeting the molecular pathogenesis of the disease. Proteolysis Targeting Chimeras (PROTACs) present a novel therapeutic strategy, leveraging the ubiquitin-proteasome system to specifically degrade the oncogenic HPV proteins E6 and E7. This targeted approach not only potentially reduces the side effects associated with conventional treatments but also directly interrupts the cancer-promoting activities of these proteins, offering a promising avenue for more effective and less invasive treatment of HPV-associated malignancies.</div></div>","PeriodicalId":100941,"journal":{"name":"Nano TransMed","volume":"4 ","pages":"Article 100071"},"PeriodicalIF":0.0,"publicationDate":"2025-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143154058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antioxidant and anti-diabetic potential of the green synthesized silver nanoparticles using Martynia annua L. root extract 黄花martyna L.根提取物绿色合成纳米银的抗氧化和抗糖尿病潜力
Nano TransMed Pub Date : 2025-01-09 DOI: 10.1016/j.ntm.2025.100070
Megha B. Abbigeri , Bothe Thokchom , Sapam Riches Singh , Santosh Mallikarjun Bhavi , B.P. Harini , Ramesh Babu Yarajarla
{"title":"Antioxidant and anti-diabetic potential of the green synthesized silver nanoparticles using Martynia annua L. root extract","authors":"Megha B. Abbigeri ,&nbsp;Bothe Thokchom ,&nbsp;Sapam Riches Singh ,&nbsp;Santosh Mallikarjun Bhavi ,&nbsp;B.P. Harini ,&nbsp;Ramesh Babu Yarajarla","doi":"10.1016/j.ntm.2025.100070","DOIUrl":"10.1016/j.ntm.2025.100070","url":null,"abstract":"<div><div>The weed <em>Martynia annua</em> traditionally known as Kakanasika is annual herbaceous plant known for its multiple medicinal properties such as anthelmintic, analgesic, antipyretic, antibacterial, anti-convulsant, anti-fertility, antinociceptive, antioxidant, CNS depressant and wound healing activity. The aqueous root extract of <em>M. annua</em> was subjected to qualitative analysis, revealing the presence of terpeniods, indicative of its rich phytochemicals composition. Utilizing a green synthesis approach, silver nanoparticles (AgNPs) were successfully synthesized from the plant extract. Characterization through UV-Visible spectroscopy, FTIR, DLS, and SEM/EDX confirmed the formation of AgNPs with polygonal morphology and an average size of 64 nm, with the PDI of 0.385. Additionally, the AgNPs demonstrated moderate stability, evidenced by a zeta potential of −21.6 mV. Evaluation of the synthesized AgNPs focused on their anti-diabetic potential. The green synthesized R-AgNPs were potent antioxidant agents. They exhibited significant inhibition of alpha amylase, a pivotal enzyme in carbohydrate metabolism, suggesting their efficacy as anti-diabetic agents. Moreover, the AgNPs enhanced glucose uptake by yeast cells, indicating their promising therapeutic role in managing diabetes mellitus. This study highlights the pharmacological importance of <em>M.annua</em>, particularly its aqueous root extract, in the eco-friendly synthesis of AgNPs with potential therapeutic implications. Further investigation into the mechanism of action and clinical efficacy of these AgNPs in diabetes management is warranted.</div></div>","PeriodicalId":100941,"journal":{"name":"Nano TransMed","volume":"4 ","pages":"Article 100070"},"PeriodicalIF":0.0,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143154056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nanocarriers in skin cancer treatment: Emerging drug delivery approaches and innovations 纳米载体在皮肤癌治疗:新兴的药物输送方法和创新
Nano TransMed Pub Date : 2024-12-17 DOI: 10.1016/j.ntm.2024.100068
Laxmi A. Jadhav, Satish K. Mandlik
{"title":"Nanocarriers in skin cancer treatment: Emerging drug delivery approaches and innovations","authors":"Laxmi A. Jadhav,&nbsp;Satish K. Mandlik","doi":"10.1016/j.ntm.2024.100068","DOIUrl":"10.1016/j.ntm.2024.100068","url":null,"abstract":"<div><h3>Background</h3><div>Skin cancer is a growing global health issue, with rising incidence rates, particularly among Caucasian populations. It is the most common malignancy, contributing significantly to mortality and decreased quality of life worldwide. While surgical interventions remain the primary treatment, there is a pressing need for innovative strategies to reduce the morbidity and mortality associated with the disease. As the burden of skin cancer continues to grow, the medical community is increasingly exploring novel therapeutic approaches to improve patient outcomes.</div></div><div><h3>Main body</h3><div>Nanotechnology has introduced new possibilities for treating skin cancer, offering advantages in targeted drug delivery, advanced imaging, and diagnostics. Nanomaterials are especially useful in dermatology, as they enhance the penetration and retention of therapeutic agents while minimizing side effects. Various nanomaterials have been studied for their potential in treating skin disorders, including cancer. This review examines the role of nanotechnology in skin cancer treatment, focusing on the development and design of nanocarriers for the precise delivery of drugs. We also discuss the advantages of nanotechnology over traditional treatments, such as improved bioavailability and targeted action. Additionally, we explore clinical trials, patents and FDA approved products related to nanocarrier-based treatments for cancer and skin cancer, highlighting advancements in the field.</div></div><div><h3>Conclusion</h3><div>Nanotechnology holds significant promise in revolutionizing skin cancer treatment. As research progresses, it is expected that more effective, personalized therapies will emerge, ultimately improving patient outcomes. Integrating nanotechnology into clinical practice could elevate the standard of care, offering new hope in managing skin cancer.</div></div>","PeriodicalId":100941,"journal":{"name":"Nano TransMed","volume":"4 ","pages":"Article 100068"},"PeriodicalIF":0.0,"publicationDate":"2024-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143154055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信